CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −486 | $584.47 | $284K | 40,793 |
| 2026-04-08 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $585.48 | $164K | 40,513 |
| 2026-04-08 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 83,500 | ||
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −39 | $556.89 | $22K | 49,974 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −276 | $558.32 | $154K | 49,698 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −365 | $559.21 | $204K | 49,333 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $560.36 | $291K | 48,813 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $561.67 | $202K | 48,453 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,069 | $562.35 | $601K | 47,384 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,449 | $563.47 | $816K | 45,935 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,512 | $564.67 | $1.4M | 43,423 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,737 | $565.66 | $983K | 41,686 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −431 | $566.63 | $244K | 41,255 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −322 | $567.64 | $183K | 40,933 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −296 | $568.74 | $168K | 40,637 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −124 | $569.62 | $71K | 40,513 |
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −7,000 | 93,000 | ||
| 2026-04-07 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −2,500 | 0 | ||
| 2026-04-06 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
Page 128 of 171 · 3,408 trades